Hyperbaric oxygen therapy in necrotising soft... (2012 study) Skip to main content
Retrospective Study Intensive care medicine 2012

Hyperbaric oxygen therapy in necrotising soft tissue infections: a study of patients in the United States Nationwide Inpatient Sample.

Soh CR, Pietrobon R, Freiberger JJ, Chew ST, Rajgor D, Gandhi M, et al., Intensive care medicine, 2012

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers looked back at hospital records from a large United States database to compare patients with a severe soft tissue infection who received hyperbaric oxygen therapy with those who did not.

What They Found

In this retrospective study of 45,913 patients with necrotising soft tissue infection, the 405 patients who received hyperbaric oxygen therapy had lower in-hospital mortality than the others, 4.5 percent versus 9.4 percent (p equals 0.001). After adjusting for predictors and confounders, the odds ratio for dying was 0.49 (95 percent confidence interval 0.29 to 0.83). Hospitalisation cost was higher with hyperbaric oxygen, US$52,205 versus US$45,464 (p equals 0.02). Length of stay was also longer, 14.3 days versus 10.7 days (p less than 0.001). The disease itself carries a significant risk of death and long-term disability from limb and tissue loss.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This was a retrospective analysis of a database, so the groups were not randomly assigned, and only 405 of the 45,913 patients received hyperbaric oxygen, which means other differences between the groups could account for part of the result.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Retrospective Study
Category Infection
Source Pubmed
PubMed ID 22527074
Year Published 2012
Journal Intensive care medicine
MeSH Terms Comorbidity; Female; Hospital Costs; Hospitalization; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Necrosis; Retrospective Studies; Soft Tissue Infections; Survival Analysis; Treatment Outcome; United States

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology